Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

562
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
562
ATP Synthase: Structure01:18

ATP Synthase: Structure

15.5K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
15.5K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

17.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
17.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.5K
Air-entraining Agents01:27

Air-entraining Agents

272
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
272
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient Valorization of Waste Surgical Masks for the Production of Activated Carbon-like Sorbent and Its Application in Solid-Phase Extraction and UHPLC-PDA Analysis of Phthalates in Water.

Molecules (Basel, Switzerland)·2026
Same author

Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization Approach.

Journal of medicinal chemistry·2025
Same author

Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics.

European journal of medicinal chemistry·2025
Same author

Quality of Life in Rectal Cancer Treatments: An Updated Systematic Review of Randomized Controlled Trials (2013-2023).

Cancers·2025
Same author

Anal cancer screening in a cohort of women with HIV: Uptake and outcomes from a prospective study in Northern Italy.

HIV medicine·2025
Same author

Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation.

ACS omega·2025

Related Experiment Video

Updated: Jan 31, 2026

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.4K

Antibacterial agent discovery using thymidylate synthase biolibrary screening.

M Paola Costi1, Arianna Gelain, Daniela Barlocco

  • 1Dipartimento di Scienze Farmaceutiche, Università degli Studi di Modena e Reggio Emilia (UNIMORE), Via Campi 183, 41100 Modena, Italy. costimp@unimore.it

Journal of Medicinal Chemistry
|September 29, 2006
PubMed
Summary

New naphthalein derivatives target thymidylate synthase (TS) to combat resistant bacteria. Compound 5 shows potent activity against vancomycin-resistant Staphylococcus epidermidis, indicating its potential as a leading antibacterial agent.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K

Related Experiment Videos

Last Updated: Jan 31, 2026

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
05:57

Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria

Published on: October 4, 2024

1.4K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K

Area of Science:

  • Medicinal Chemistry
  • Antimicrobial Drug Discovery
  • Enzyme Inhibition

Background:

  • Thymidylate synthase (TS) is crucial for bacterial DNA synthesis, making it a target for antibacterial agents.
  • Inhibition of TS leads to bacterial cell death.
  • Developing new agents against resistant strains is a critical unmet medical need.

Purpose of the Study:

  • To synthesize and evaluate novel 1,2-naphthalein derivatives as inhibitors of thymidylate synthase.
  • To identify potent antibacterial compounds effective against drug-resistant Gram-positive bacteria.
  • To investigate the structure-activity relationship of naphthalein derivatives against bacterial TS.

Main Methods:

  • Synthesis of new 1,2-naphthalein derivatives.
  • In vitro testing against a thymidylate synthase biolibrary, including human TS.
  • Molecular docking studies to predict binding affinities.
  • Antimicrobial susceptibility testing against clinical isolates of resistant Gram-positive bacteria.

Main Results:

  • Compound 5, a 1,2-naphthalein derivative, demonstrated significant antibacterial activity.
  • Compound 5 exhibited no in vitro toxicity.
  • Compound 5 showed dose-response effects against vancomycin-resistant Staphylococcus epidermidis (MIC=0.5-2.5 microg/mL).

Conclusions:

  • Compound 5 is a promising leading antibacterial agent with potent activity against multidrug-resistant Gram-positive bacteria.
  • The naphthalein scaffold is a viable starting point for developing novel TS inhibitors.
  • Further development of compound 5 could address the challenge of antibiotic resistance.